Dr. Jennifer Temel, Clinical Director of Thoracic Oncology, sat down with 98.5 The Sports Hub's Bob Socci to discuss a new effort at the Mass General Cancer Center to offer patients who may have a lung cancer diagnosis next day appointments.
Mass General Cancer Center
55 Fruit St
Boston, MA 02114
Support Lung Cancer Research
Your gift will help our team advance research into new, targeted therapies to improve outcomes for patients with lung cancer. Make a gift.
Explore the Lung Cancer Treatment Program
At the Center for Thoracic Cancers, our multidisciplinary team of lung cancer specialists put together a comprehensive treatment plan just for you. Many lung patients benefit from our approach. You will see lung cancer specialists from medical oncology, radiation oncology and surgery. We:
- Offer a collaborative approach to lung cancer diagnosis and treatment
- Provide care and support tailored to each patient’s needs
- Combine clinical expertise, cutting-edge research and medical technologies to offer patients the most appropriate therapies
- Ensure patients fully understand their diagnosis and treatment options
- View patients and their family and friends involved in their care as team members
Patients are usually seen within one week of referral.
The Center for Thoracic Cancers is among the first in the nation to provide new targeted therapies for non-small cell lung cancer. Consistently ranked as one of the best in the country by U.S. News & World Report, we provide the promising new therapies and innovative approaches to clinical care, including:
- Expertise in minimally invasive surgery for lung cancer, including lung-sparing techniques
- Genotyping (molecular fingerprinting) to determine which lung cancers carry genetic mutations that might be treated with targeted therapies
- Rapid diagnosis and staging of all biopsied tumors by pathologists who specialize in lung cancer
- Groundbreaking research regarding the molecular basis of some lung cancers
- The Francis Burr Northeast Proton Therapy Center, New England’s only proton radiation facility
- Access to one of New England’s only Advanced Endoscopy Services
Expertise in Diagnosing and Staging Lung Cancer
All members of our team of pathologists and radiologists are nationally recognized for their expertise. Our pathologists participate in weekly tumor board meetings, sharing information about each patient’s unique cancer with the entire team to help guide care planning. Our radiologists use the most advanced imaging tools to diagnose and stage thoracic cancers and to detect changes in tumors. Our imaging methods include:
- Chest radiograph
- Computed tomography scan (CT or CAT scan)
- PET and nuclear medicine scans
- Our minimally invasive image-guided procedures for diagnosis include:
- Percutaneous needle biopsy and molecular diagnostic tests
- Esophageal ultrasound
- Navigation bronchoscopy for biopsy of peripheral lung nodules
Advancing Medical Oncology
Some new cancer drugs currently available or in development are designed to block some of the mutations that cause tumors to grow. By targeting tumor gene mutations with these “smart drugs”, our doctors are beginning to understand how to destroy cancer cells in some patients' tumors without traditional chemotherapy and radiation.
We are among a select few health care institutions in the world to offer comprehensive genotyping of thoracic cancers as a routine component of our pathological assessment. This genotyping allows us to test each tumor for certain genetic mutations. These genetic markers indicate certain weaknesses in an individual’s cancer; weaknesses that we can exploit using targeted therapies. By understanding the genetics behind each lung tumor we are able to choose the specific type of treatment that will be most effective for that particular patient’s cancer. Learn more about genotyping.
Excellence in Surgical Care
Our team of dedicated surgeons treats some of the most challenging and complex cases from across the US. We focus only on thoracic surgery and have pioneered many now-standard procedures used to treat thoracic cancers. The team provides state-of-the-art evaluation, treatment and post-surgical services, including:
- Chest and airway reconstruction
- Laser surgery
- Minimally invasive video-assisted thorascopic surgery
- Resection of tumors in the chest wall, lungs and mediastinum
- Lung-sparing techniques for benign and malignant neoplasms of the lung
- Resection of tumors obstructing a bronchus or in the trachea
We offer many minimally invasive surgical procedures, such as:
- Bronchoscopy to explore the bronchial passages
- Navigation bronchoscopy to biopsy peripheral lung nodules or placement of radiosurgical markers to enhance tracking of the lung tumors during radiation treatment
- Esophagoscopy to sample lymph nodes around the airway or lung
- Mediastinoscopy to explore the area between the lungs and nearby lymph nodes
- Thoracoscopy to explore the thorax
- Esophageal endoscopic ultrasound
- Endobronchial ultrasound
Pioneering Radiation Therapy Programs
Specialists in the Thoracic Radiation Oncology Program employ high-precision radiation therapy to treat patients with lung cancers and other cancers in the chest with the overarching goal of causing little or no side effects. Pioneering technological advances for the benefit of our patients include:
- Intensity-modulated radiation therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) for reducing side effects and improving tumor kill
- Stereotactic Body Radiation Therapy (SBRT) for the treatment of early stage lung cancers and increasingly also metastatic cancers
- 4-dimensional (4D) CT scanning and respiratory gating for treatment of lung tumors that move around with breathing
- Proton beam therapy in patients with certain lung cancers
Our radiation oncologists are part of a highly specialized multidisciplinary team that closely coordinates the care of each patient. Cutting-edge research aims at increasing the efficacy and reducing the side effects of radiation therapy as well as integrating radiation with revolutionizing biological drug therapies.
For more information, please see the Thoracic Radiation Oncology Program.
Clinical trials are research studies which are conducted to answer questions. They can test many things including new drugs, new combinations of drugs, or already approved drugs being studied to treat patients in new or different ways. They may include new drug doses or new ways (schedules) to give the drugs. Clinical trials are run under strict guidelines with specific criteria for eligibility and treatment. Their purpose is to help find out whether new cancer treatments are safe and effective or better than the standard (current) treatment.
The Mass General Hospital Thoracic Oncology Program has a very active clinical research portfolio with the latest, top-notch investigational studies covering a wide spectrum of thoracic cancer care. The ultimate goal of clinical research is to improve the outcomes for all of our patients. If you are eligible for a clinical trial, your physician will offer you the chance for participation. We will comprehensively review the logistics and purpose of the trial and also offer alternatives including the standard of care.
Meet the Team
Our team approach ensures that every patient benefits from a personalized, coordinated and compassionate treatment plan that includes leading experts across many specialties. Members of your care team meet regularly with you and contact your referring physician on an ongoing basis to ensure clear communication and a seamless coordination of care.
- Director of Thoracic Oncology
- Paula O'Keeffe Endowed Chair in Thoracic Oncology
- Professor of Medicine at Harvard Medical School
- Director, Thoracic Radiation Oncology Program
- Associate Professor, Harvard Medical School
- Clinical Director of Thoracic Oncology
- Director, Cancer Outcomes Research Program
- Professor of Medicine at Harvard Medical School
- Director, Thoracic Oncology, Division of Thoracic Surgery
- Chief, Division of Thoracic Surgery
- Professor of Surgery
Patient Education & Resources
Cancer that begins in any part of the lungs is called lung cancer. The two basic types of lung cancer are non-small cell lung cancer and small cell lung cancer.
We work with patients to develop personalized follow-up care following review of CT scans.
A free, phone-based, one-on-one tobacco counseling resource for Cancer Center patients.
Learn more about Mass General's Thoracic Radiation Oncology Program.
A checklist of items to bring with you for your first visit and helpful information.
We offer a wide range of integrative therapies, workshops and support groups.
These stories highlight the strength, courage and resiliency of our patients, and the coordinated effort of the thoracic oncology team to provide the best possible care.
"I was never afraid of coming here. I’ve always felt right at home. I actually enjoy coming here at this point. I have so many friends that have gone beyond the doctor-patient relationship. They are truly friends."
"I was the first patient enrolled in the initial EGFR-targeted therapy clinical trial at Mass General. I didn’t have any hesitancy about starting a clinical trial because I had so much confidence in Mass General and in my team that I believed it had to be the best option.”
View recent research presentations given by the thoracic oncology team.
Next-generation ALK inhibitors
Watch Dr. Alice Shaw discuss two recent studies on next-generation ALK inhibitors for ALK-positive lung cancer patients.
Honors & Awards
View thoracic oncology team members honored for their commitment to the fight against cancer.
Justin Gainor, MD
Dr. Gainor conducts intensive research on developing novel targeted therapies for patients with genetically-defined forms of lung cancer and designs clinical trials to evaluate these complex, life-saving treatments.
Natasha Johnson, MSW, LICSW
An attentive listener with a gentle touch, oncology social worker Natasha Johnson takes special care to understand each patient, tailoring suggestions to reflect his or her needs.
Inga T. Lennes, MD, MPH, MBA
A medical oncologist specializing in lung and esophageal cancers, Dr. Lennes is also the founder and director of the Pulmonary Nodule Clinic and works closely with colleagues to study and implement lung cancer screening and improve nodule management.
Lecia Sequist, MD, MPH
Dr. Sequist provides outstanding and compassionate patient care. Her patients trust her, and she is at the top of her game both in the care of lung cancer patients and in leading research and education to advance current care.
Alice T. Shaw, MD, PhD
Alice Shaw, MD, PhD treats her patients with the best of science and the best of humanity. “Alice is my super-hero. She is contributing to the future of cancer research and treatment. And she is doing her best to make sure I have a future as well.”
- Nov | 26 | 2019
Mass General Cancer Center’s Dr. Jennifer Temel, Clinical Director of Thoracic Oncology, explains what patients can expect during a multidisciplinary appointment.
- Patient Story
- Jun | 7 | 2019
A lifelong Massachusetts resident, Jerry Remy knew coming to the Mass General Cancer Center was putting his care in the best hands possible.